This article is more than 5 years old. Information may no longer be current.
Telemedicine ‘feasible, effective’ in treating patients with migraine
PHILADELPHIA — Telemedicine proved to be a reasonable and beneficial alternative to in-office visits for follow-up in patients with migraine, study findings presented during the American Headache Society Annual Scientific Meeting indicated.
Researchers reviewed results from 30 patients randomly assigned in an approximate 1:1 ratio to obtain follow-up care from either five telemedicine or five in-office visits during a 1-year period.
They found that 89 of 96 scheduled telemedicine visits were successfully completed. In addition, the number of headache days, improvement in Migraine Disability Assessment score and average severity at 12 months were noninferior in the telemedicine cohort vs. the in-office group. Also, convenience was rated higher and visit times were shorter in the telemedicine cohort.
“Telemedicine was a feasible mode of treatment and an effective alternative to in-office visits for follow-up of migraine. Physician productivity could be higher with telemedicine and patients may have better access because of its convenience,” researchers concluded. – by Janel Miller
Reference: A randomized trial of telemedicine for migraine management. Presented at: American Headache Society Annual Scientific Meeting; July 11-14, 2019; Philadelphia. Submission ID: 679616.
Disclosures: Healio Primary Care was unable to determine Friedman’s relevant financial disclosures prior to publication.